121 related articles for article (PubMed ID: 36058128)
1. Breast cancer mortality of older patients with and without recurrence analysed by novel multi-state models.
de Boer AZ; Bastiaannet E; Schetelig J; de Glas NA; Manevksi D; Putter H; Liefers GJ; de Munck L; Portielje JEA; de Wreede LC
Eur J Cancer; 2022 Oct; 174():212-220. PubMed ID: 36058128
[TBL] [Abstract][Full Text] [Related]
2. Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.
de Boer AZ; van der Hulst HC; de Glas NA; Marang-van de Mheen PJ; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Bastiaannet E; Liefers GJ
Oncologist; 2020 Jan; 25(1):e24-e30. PubMed ID: 31515242
[TBL] [Abstract][Full Text] [Related]
3. Predictors of time to death after distant recurrence in breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
[TBL] [Abstract][Full Text] [Related]
4. Estimating the incidence of breast cancer recurrence using administrative data.
Habbous S; Barisic A; Homenauth E; Kandasamy S; Forster K; Eisen A; Holloway C
Breast Cancer Res Treat; 2023 Apr; 198(3):509-522. PubMed ID: 36422755
[TBL] [Abstract][Full Text] [Related]
5. Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand.
Chairat R; Puttisri A; Pamarapa A; Wongrach N; Tawichasri C; Patumanond J; Tantraworasin A; Charoentum C
J Med Assoc Thai; 2014 Sep; 97(9):932-8. PubMed ID: 25536710
[TBL] [Abstract][Full Text] [Related]
6. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Anderson SJ; Wapnir I; Dignam JJ; Fisher B; Mamounas EP; Jeong JH; Geyer CE; Wickerham DL; Costantino JP; Wolmark N
J Clin Oncol; 2009 May; 27(15):2466-73. PubMed ID: 19349544
[TBL] [Abstract][Full Text] [Related]
7. Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01).
Neuman HB; Schumacher JR; Francescatti AB; Adesoye T; Edge SB; Vanness DJ; Yu M; McKellar D; Winchester DP; Greenberg CC;
J Clin Oncol; 2018 Apr; 36(10):975-980. PubMed ID: 29384721
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.
de Boer AZ; Bastiaannet E; de Glas NA; Marang-van de Mheen PJ; Dekkers OM; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Liefers GJ
Breast Cancer Res Treat; 2019 Dec; 178(3):637-645. PubMed ID: 31451977
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and recurrence patterns in patients with early stage lung cancer: a multi-state model approach.
Jeong WG; Choi H; Chae KJ; Kim J
Transl Lung Cancer Res; 2022 Jul; 11(7):1279-1291. PubMed ID: 35958321
[TBL] [Abstract][Full Text] [Related]
10. Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.
van de Water W; Seynaeve C; Bastiaannet E; Markopoulos C; Jones SE; Rea D; Hasenburg A; Putter H; Hille ET; Paridaens R; de Craen AJ; Westendorp RG; van de Velde CJ; Liefers GJ
Oncologist; 2013; 18(1):8-13. PubMed ID: 23263290
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
[TBL] [Abstract][Full Text] [Related]
12. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy.
Waaijer MEC; Lemij AA; de Boer AZ; Bastiaannet E; van den Bos F; Derks MGM; Kroep JR; Liefers GJ; Portielje JEA; de Glas NA
Breast Cancer Res Treat; 2023 Oct; 201(3):471-478. PubMed ID: 37479944
[TBL] [Abstract][Full Text] [Related]
13. Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.
Michel LL; Sommer L; González Silos R; Lorenzo Bermejo J; von Au A; Seitz J; Hennigs A; Smetanay K; Golatta M; Heil J; Schütz F; Sohn C; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Sep; 177(2):437-446. PubMed ID: 31236813
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands.
van Maaren MC; Rachet B; Sonke GS; Mauguen A; Rondeau V; Siesling S; Belot A
Cancer Epidemiol; 2022 Apr; 77():102118. PubMed ID: 35131686
[TBL] [Abstract][Full Text] [Related]
15. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
Wapnir IL; Anderson SJ; Mamounas EP; Geyer CE; Jeong JH; Tan-Chiu E; Fisher B; Wolmark N
J Clin Oncol; 2006 May; 24(13):2028-37. PubMed ID: 16648502
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
[TBL] [Abstract][Full Text] [Related]
18. Mortality After Late Breast Cancer Recurrence in Denmark.
Pedersen RN; Mellemkjær L; Ejlertsen B; Nørgaard M; Cronin-Fenton DP
J Clin Oncol; 2022 May; 40(13):1450-1463. PubMed ID: 35171656
[TBL] [Abstract][Full Text] [Related]
19. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system.
Fehrenbacher L; Capra AM; Quesenberry CP; Fulton R; Shiraz P; Habel LA
J Clin Oncol; 2014 Jul; 32(20):2151-8. PubMed ID: 24888815
[TBL] [Abstract][Full Text] [Related]
20. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
Fodor J
Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
